Pfizer Booster Approved for Children 5 to 11

May 20, 2022
Pfizer Booster Approved for Children 5 to 11


The Pfizer COVID-19 booster is now available for children ages 5 to 11. 

The U.S. Food and Drug Administration (FDA) has approved under emergency use authorization (EUA) the single booster dose of the Pfizer COVID-19 vaccine for children ages 5 to 11.

To help you stay informed, below is information on the Pfizer booster dose and what you can expect.

What is a Booster Shot? 

The booster shot is an additional dose of the COVID-19 vaccine. Scientific data shows that an additional booster shot helps increase the immune response and improve protection against severe COVID-19. 

How is the Booster Shot Administered?

Children ages 5 to 11 can receive their Pfizer booster dose at least five months after completing their primary two-dose series. Children in this age range receive a lower dose (10 micrograms) than individuals 12 years of age and older (30 micrograms). According to FDA, receiving the additional booster dose outweighs potential risks, giving children protection against severe COVID-19. 

What are the Risks? 

After receiving the COVID-19 vaccine, children may experience some common side effects, similar to that of individuals 12 and older, that typically go away after a few days. This is a normal sign that your body is building protection. The most common side effects from the COVID-19 vaccine may include redness or swelling where the shot was given, fever, fatigue, headache, muscle pain, chills and joint pain.  

Does BayCare Offer Booster Shots? 

BayCare does not provide COVID-19 vaccines or booster shots from Pfizer, Moderna and Johnson & Johnson. Vaccines, including the booster shots, are widely available through local community settings and retail pharmacies across the Tampa Bay area.  

For more information, visit  


Featured Video

BayCare Thrives as a Powerful Economic Engine in Florida

Image Gallery

BayCare Podcasts